The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bozhok A.A.

Saint Petersburg State Pediatric Medical University

Kashchenko V.A.

Sokolov North-Western Regional Scientific Clinical Center

Ratnikov V.A.

Sokolov North-Western Regional Scientific Clinical Center

Gornov S.V.

Russian Biotechnological University

Suvorova Yu.V.

Sokolov North-Western Regional Scientific Clinical Center

Manelov A.E.

Mechnikov North-Western State Medical University

Fluorescence lymphography for sentinal lymph node biopsy in breast cancer

Authors:

Bozhok A.A., Kashchenko V.A., Ratnikov V.A., Gornov S.V., Suvorova Yu.V., Manelov A.E.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2024;(2‑2): 48‑54

Read: 1717 times


To cite this article:

Bozhok AA, Kashchenko VA, Ratnikov VA, Gornov SV, Suvorova YuV, Manelov AE. Fluorescence lymphography for sentinal lymph node biopsy in breast cancer. Pirogov Russian Journal of Surgery. 2024;(2‑2):48‑54. (In Russ.)
https://doi.org/10.17116/hirurgia202402248

Recommended articles:
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83

References:

  1. Cabanas R. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456-466.  https://doi.org/10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i
  2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery. 1994;220(3):391-401.  https://doi.org/10.1097/00000658-199409000-00015
  3. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surgical Oncology. 1993;2(6):335-340.  https://doi.org/10.1016/0960-7404(93)90064-6
  4. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, Renier M, Racano C, Carraro P, Nitti D; GIVOM Trialists. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella. Annals of Surgery. 2008;247 (2):207-213.  https://doi.org/10.1097/SLA.0b013e31812e6a73
  5. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. New England Journal of Medicine. 2003;349(6):546-553.  https://doi.org/10.1056/NEJMoa012782
  6. Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F, Gatti G, Mazzarol G, De Cicco C, Vezzoli D. Sentinel lymph node biopsy in breast cancer: ten year results of a randomized controlled study. Annals of Surgery. 2010;251(4):595-600.  https://doi.org/10.1097/SLA.0b013e3181c0e92a
  7. Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Villa G, Carli F, Bruzzi P, Dozin B. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Annals of Oncology. 2009;20(6):1001-1007. https://doi.org/10.1093/annonc/mdn746
  8. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet. Oncology. 2010;11(10):927-933.  https://doi.org/10.1016/S1470-2045(10)70207-2
  9. Petrelli F, Lonati V, Barni S. Axillary dissection compared to sentinel node biopsy for the treatment of pathologically node-negative breast cancer: a meta-analysis of four randomized trials with long-term follow up. Oncology Reviews. 2012;6(2):e20.  https://doi.org/10.4081/oncol.2012.e20
  10. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19(3):210-213.  https://doi.org/10.1016/j.breast.2010.01.014
  11. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12(3):211-215.  https://doi.org/10.2325/jbcs.12.211
  12. Xiong L, Gazyakan E, Yang W, Engel H, Hünerbein M, Kneser U, Hirche C. Indocyanine green fluorescence-guided sentinel node biopsy: a meta-analysis on detection rate and diagnostic performance. European Journal of Surgical Oncology. 2014;40(7):843-849.  https://doi.org/10.1016/j.ejso.2014.02.228
  13. Ballardini B, Santoro L, Sangalli C, Gentilini O, Renne G, Lissidini G, Pagani GM, Toesca A, Blundo C, del Castillo A, Peradze N, Caldarella P, Veronesi P. The indocyanine green method is equivalent to the 99 mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. European Journal of Surgical Oncology. 2013;39(12):1332-1336. https://doi.org/10.1016/j.ejso.2013.10.004
  14. Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK. Le-Petross et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy. Annals of Oncology. 2016;263(4):802-807.  https://doi.org/10.1097/SLA.0000000000001375
  15. Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, Vicini E, Morigi C, Corso G, Intra M, Canegallo F, Ratini S, Leonardi MC, La Rocca E, Bagnardi V, Montagna E, Colleoni M, Viale G, Bottiglieri L, Grana CM, Biasuz JV, Veronesi P, Galimberti V. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up. European Journal of Surgical Oncology. 2021;47(4):804-812.  https://doi.org/10.1016/j.ejso.2020.10.014
  16. Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio A, Morrow M. Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection? Annals of Surgical Oncology. 2018;25(6):1488-1494. https://doi.org/10.1245/s10434-018-6429-2
  17. Almahariq MF, Levitin R, Quinn TJ, Chen PY, Dekhne N, Kiran S, Desai A, Benitez P, Jawad MS, Gustafson GS, Dilworth JT. Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual N1 nodal disease following neoadjuvant chemotherapy. Annals of Surgical Oncology. 2021;28(2):930-940.  https://doi.org/10.1245/s10434-020-08928-2
  18. Krivorot’ko PV, Kanaev SV, Semiglazov VF, Novikov SN, Krzhivickij PI, Semenov II, Turkevich EA, Bus’ko EA, Donskih RV, Bryanceva ZHV, Piskunov EA, Trufanova ES, Chernaya AV. Methodological problems of biopsy of signaling lymph nodes in patients with breast cancer. Voprosy onkologii. 2015;61(3):418-423. (In Russ.).
  19. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology. 2000;93(4):145-146.  https://doi.org/10.1097/00000542-200010000-00041
  20. Rescigno J, Zampell JC, Axelrod D. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Annals of Surgical Oncology. 2009;16(3):687-696.  https://doi.org/10.1245/s10434-008-0195-5
  21. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Japanese Journal of Clinical Oncology. 1999;29(12):604-607.  https://doi.org/10.1093/jjco/29.12.604
  22. Sugie T, Kassim KA, Takeuchi M, Hashimoto T, Yamagami K, Masai Y, Toi M.A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer. Cancers. 2010;2(2):713-720.  https://doi.org/10.3390/cancers2020713
  23. Hirche C, Murawa D, Mohr Z, Kneif S, Hünerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Research and Treatment. 2010;121(2):373-378.  https://doi.org/10.1007/s10549-010-0760-z
  24. Abe H, Mori T, Umeda T, Tanaka M, Kawai Y, Shimizu T, Cho H, Kubota Y, Kurumi Y, Tani T. Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients. Surgery Today. 2011;41(2):197-202.  https://doi.org/10.1007/s00595-009-4254-8
  25. Wishart GC, Loh SW, Jones L, Benson JR. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. European Journal of Surgical Oncology. 2012;38(8):651-656.  https://doi.org/10.1016/j.ejso.2012.05.007
  26. Murawa D, Hirche C, Dresel S, Hünerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. British Journal of Surgery. 2009;96(11):1289-1294. https://doi.org/10.1002/bjs.6721
  27. Yin R, Ding LY, Wei QZ, Zhou Y, Tang GY, Zhu X. Comparisons of ICG-fluorescence with conventional tracers in sentinel lymph node biopsy for patients with early-stage breast cancer: A meta-analysis. Oncology Letters. 2021;21(2):114.  https://doi.org/10.3892/ol.2020.12375

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.